Trial Details
COMPLETEDBasic Information
| Clinical ID | c4622 |
|---|---|
| Identifier | NCT00245947 |
| Trial Title | Study Evaluating ERB-041 in Active Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: ERB-041 |
Participant Information
| Sponsor | Wyeth is now a wholly owned subsidiary of Pfizer |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2004-04 |
|---|---|
| Primary Completion Date | 2005-04 |
| Completion Date | 2005-04 |